The purpose of this study was to evaluate the feasibility and benefits of using high-dose-rate three-dimensional conformal radiotherapy (3D-CRT) combined with active breathing control (ABC) for stereotactic body radiotherapy (SBRT) of patients with early-stage non-small-cell lung cancer (NSCLC). Eight patients with early-stage NSCLC underwent CT scans under standard free-breathing (FB) and moderately deep inspiration breath-hold (mDIBH) with ABC. Two high-dose-rate 3D-CRT plans (1000 Mu/min) were designed based on the CT scans with FB and mDIBH. The maximal dose (D 1% ), minimal dose (D 99% ), conformity index (CI), and homogeneity index (HI) of the planning target volume (PTV), and dose-volume indices of the organs at risk between each plan were compared. The mean PTV volume decreased from 158.04 cm 3 with FB to 76.90 cm 3 with mDIBH (p  0.05). When mDIBH was used, increases in the affected lung volume (by 47%), contralateral lung volume (by 55%), and total lung volume (by 50%) were observed compared to FB (p  0.05). The V 5 V 40 of the affected lung (V x represented the percentage volume of organs receiving at least the x Gy), V 5 V 40 and the mean dose for the total lung, V 5 V 40 and mean dose of the chest wall, and the maximum dose of the spinal cord were less for mDIBH than FB (p  0.05). There were no significant differences in CI, HI, D 1% , or D 99% for the PTV between the plans. In conclusion, high-dose-rate 3D-CRT combined with ABC reduced the radiation dose to the lungs and chest wall without affecting the dose distribution in SBRT of early-stage NSCLC patients.
Introduction
Stereotactic body radiotherapy (SBRT) allows improved local control and overall survival for patients with inoperable early-stage non-small cell lung cancer (NSCLC) (1) (2) (3) (4) . The two most important factors for SBRT of NSCLC are accurate positioning for tumor targeting and minimizing side effects (3, 5) . Organ motion induced by respiration presents a challenge to precise targeting of radiotherapy to lung tumors, especially when tumors are small. As a result of organ motion, the radiotherapy doses may be less heterogeneous or the target tumor may not receive direct irradiation (5, 6) . Active breathing control (ABC) and four-dimensional computed tomography (4D-CT) improve the spatial accuracy for early-stage NSCLC (7) (8) (9) . ABC temporarily minimizes breathing motions and increases the absolute volume of lungs at the end of a moderately deep inspiration breath hold (mDIBH), thereby could reduce pulmonary radiation injury (10, 11) . Combinations of several therapeutic techniques could also better preserve the organs at risk (OARs) (8) .
The number of radiation fields and irradiation time for a single field are critical factors for the reproducibility and stability in SBRT with ABC. The effectiveness of ABC can be improved by employing fewer radiation fields. Additionally, the use of shorter exposure times for any single field, which are primarily determined by the radiation delivery dose rate, could also improve the effectiveness of ABC. Several groups have reported the dosimetric and preliminary clinical benefits applying flattening filter-free irradiation in high-doserate (which could reach to 2400 Mu/min) SBRT (12, 13) . Although both high-dose-rate radiation technology and ABC could improve the outcomes of SBRT, no study has evaluated the effect of using both techniques for SBRT of NSCLC. Therefore, this study investigated the feasibility of applying high-dose-rate 3D-CRT combined with ABC in patients with early-stage NSCLC.
Materials and Methods

Patients Information
Eight NSCLC patients (6 males and 2 females, aged from 67 to 82 years) were included in the study between May 2011 and October 2012 in Shandong Tumor Hospital and Affiliated Tumor Hospital of Xinjiang Medical University. The average age was 72 years (range, 67-82 years). There were 6 patients with lung squamous cell and 2 patients with lung adenocarcinoma. The case inclusion criteria were as follows: 1) peripheral NSCLC; 2) a tumor diameter 3 cm; 3) no mediastinal lymph node involvement or distant metastasis; 4) no history of chest radiotherapy; 5) an Eastern Cooperative Oncology Group (ECOG) score between 0 and 1. All enrolled patients signed informed consent forms. The study protocol was approved by the ethics committees at the Shandong Cancer Hospital and Affiliated Tumor Hospital of Xinjiang Medical University.
Computed Tomography (CT) Simulation
Two series of CT scans were performed under FB (CT FB ) or mDIBH (CT mDIBH ) with ABC (trigger threshold was set at 75-80% of maximum inspiration capacity). All patients were in the supine position and given an initial coaching session before scanning. The CT scan region was from the cricoid cartilage to the lower edge of the costophrenic angle and included the whole lung. Sequential images were obtained with a slice thickness of 3 mm. Tumors and OARs were contoured by using an Eclipse planning system (Version 8.6, Varian Medical Systems, Palo Alto, CA, USA).
Acquisition of GTVs and PTVs
The gross tumor volume (GTV) was determined on CT FB images and referenced to diagnostic positron emission tomography-computed tomography (PET-CT) images. The planning target volume (PTV) from CT FB images was determined from the GTV, with margins of 2.0 cm in the cranio-caudal direction and 1.5 cm in the left-right and anterior-posterior axes (14) . The GTV mDIBH was determined from CT mDIBH . PTV mDIBH contained GTV mDIBH plus 8 mm margins in all directions. All margins contained the 5 mm distance between the GTV and PTV (15) .
Radiotherapy Planning and Treatment
Treatment plans were designed for a Varian Trilogy linear accelerator using Varian Eclipse planning system and optimized with a 6 MV-SRS model. Dose rates were set at 1000 Mu/Min. The 3D-CRT field angle was determined according to the tumor location. Six coplanar fields were chosen and the prescribed dose was set at 10.0 Gy/fraction 3 6 fractions (3). An analytical anisotropic algorithm was used to calculated radiation doses.
Analyzed Parameters
Parameters that were recorded and compared between the plans under FB and mDIBH included: absolute lung volume, GTV, PTV, D 1% , D 5% , D 95% , and D 99% (radiation doses received by 1%, 5%, 95%, and 99% of the PTV respectively). Two additional parameters were calculated to quantify and compare plans at FB and mDIBH: the homogeneity index (HI, where HI 5 D 5% /D 95% ) and the conformity index (CI). The CI is determined by the following equations: CI 5 CF 3 SF, where CF 5 V DT-PTV/ V DT, and SF 5 V DT-PTV /V PTV , and V DT-PTV is defined as the volume of PTV receiving the prescribed dose, V DT is the total volume receiving the prescribed dose, and V PTV is the PTV. CI and HI values closest to 1 represent the best dose conformity and homogeneity. D mean describes the mean dose received by the OARs or the PTV. D max denotes the maximum dose received by the spinal cord. V x was defined as the percentage volume of organs receiving at least the x Gy of radiation and was used to evaluate the OARs.
Statistical Analyses
All data values are presented as mean 6 SD (x _ ± S) and
were analyzed using SPSS software (Version 17.0, Chicago, IL, USA). Experimental groups were compared by pairedsample t-tests. p-values  0.05 were considered statistically significant. 
Results
Volumes of Target Volumes and OARs
The GTVs determined by mDIBH and FB were not statistically different (p  0.05). However, the mean PTV decreased from 158.04 cm 3 with FB to 76.90 cm 3 with mDIBH (p  0.05). The volume of the affected lung increased from 1978.77 cm 3 with FB to 2910.88 cm 3 with mDIBH, and the contralateral lung increased from 1726.55 cm 3 to 2671.13 cm 3 , the total lung volume also increased from 3745.26 cm 3 to 5615.85 cm 3 (Table I) , p-values for all comparisons were 0.05.
Parameters for PTV and Monitor Unit
The CI, HI, D 1% , D 99% , and monitor units were similar between both plans (p  0.05) (Table II) .
Dose-volume Indexes of Treated, Contralateral, and Total Lung Volumes
The V 5 V 40 of affected lungs were significantly decreased when using mDIBH compared to FB (Table III) . In contrast, the V 5 V 15 of contralateral lungs were not significantly different between mDIBH and FB. The V 5 V 40 and D mean of the whole lung volume (Table IV) . 
Dose-volume Indices of Chest Wall, Spinal Cord and Heart
The dose-volume indices chest wall, and the D max of the spinal cord, were significantly lower with mDIBH than FB (p  0.05). However, no differences were observed in the V 20 V 40 or the D mean of the heart between the two methods (p  0.05) (Table V) .
Discussion
Dose escalation in radiotherapy of NSCLC is an important approach for improving local tumor control rates and overall survival. However, conventional dose escalation also increases the risk of radiation toxicity to normal tissue surrounding tumors (16, 17) . SBRT has the advantage of achieving dose escalations within short time periods and attaining greater biologically effective doses (BEDs), where BED 5 nd (1 + d/α/α) and n is the number of fractions, d is the dose per fraction, and α are preset as 10 (18). SBRT for early NSCLC treatment could achieve a local control rate of 85%-95% without increasing the acute or delayed normal tissue toxicity (19) (20) (21) . In this study, the dose fractionation was 10 Gy/f 3 6f (BED 5 120 Gy), consistent with that reported previously (22, 23).
We chose high-dose-rate 3D-CRT over RapidArc or intensity-modulated radiotherapy to avoid the uncertainties that are inherent in dividing larger irradiation fields into several subfields to deliver radiation doses (24, 25) . First, irreparable damage is caused by multi-leaf collimator positioning errors that can occur during treatment with a dose rate of 1000 Mu/min. Second, transient fluctuations in the dose rate occur during the adjustment of the orientation of the radiation beam to treat different subfields. Such fluctuations can negatively affect the accuracy of radiation dose delivery. Both RapidArc and intensity-modulated radiotherapy can deliver substantial radiation to OARs, leading to unpredictable biological effects for patients who could survival for long time after receiving SBRT. Therefore, 3D-CRT could be a better option when high radiotherapy dose rates are chosen for SBRT. High-dose-rate 3D-CRT can significantly reduce the treatment time and, therefore, the error caused by intra-fraction organ motion and tumor motion (25) . Most common linear accelerators are equipped with the 6 MV-SRS system, which can easily achieve a dose rate of 1000 Mu/min (sufficient to perform SBRT on many types of cancer), although it cannot achieve dose rates 2400 Mu/min.
Respiration leads to tumor motion, which changes the position of radiation targets. This tumor motion cannot be resolved by external fixation. The mDIBH approach immobilizes tumors by transiently suspending respiration through active airflow blocking. It reduces the lung density by expanding the lung volume, which could be beneficial for radiotherapy of lung carcinoma (22). The mDIBH approach provided greater protection to normal lungs and OARs, and it has been demonstrated to be safe and feasible for radiotherapy of breast cancers and lymphomas (26) (27) (28) .
A previous study showed that mDIBH minimized respiration-induced tumor motions which were most prominent along the sagittal (Z) axis (29) . In our study, the PTV mDIBH included an extra 3 mm margin from the GTV to account for the reproducibility of the tumor position during breath holding. The PTV FB required an extra 10 mm in the left-right and anterior-posterior directions, and an additional 15 mm in the cranio-caudal direction, to account for the uncertainty introduced by breathing motions during CT, while these margins may be unnecessarily large to ensure adequate PTV coverage (14, 15) . The mean PTV decreased by 50%, which significantly reduced the irradiated region in the normal lungs. Moreover, the slightly larger GTV mDIBH determined in this study, although not statistically significant, may reduce the possibility of CT scan missing portions of the GVT resulting from the breath motion randomness of 3D-CT scanning. This trend of increased GTV by mDIBH could be partially explained by the retraction force on tumors due to alveolar over-inflation at deep inspiration breath holding.
There were also significant differences in the dose-volume indices of the OARs between mDIBH and FB. The V 5 V 50 and mean lung dose were reported to correlate with radiation pneumonitis (24, 25, 30, 31) . The V 5 and V 20 could predict radiation pneumonitis at grades 2 or higher. The V 30 was most closely associated with chest pain, especially when V 30 was 70 cm 3 (32) . In this study, decreases were noted in the following parameters: V 5 V 40 of affected lungs, V 5 V 40 and D mean of total lung volume and chest walls, D max of spinal cord, V 5 V 15 of the contralateral lungs, V 20 V 40 and D mean of hearts. These decreases suggest that ABC mDIBH might reduce radiation injury in normal lung tissue, the chest wall, spinal cord, heart, and other OARs. Although 4D-CT could increase prescribed doses by reducing the margins from GTV to PTV, the reduction in dose volume indices would not be as significant as those achieved in this study because the lung volume would not increase noticeably. Moreover, variations in breathing motion cannot be neglected in radiotherapy of lung cancer using 4D-CT (33, 34) .
3D-CRT combined with ABC techniques can be used in SBRT for early-stage NSCLC, because these patients rarely suffer from pulmonary dysfunction and can hold their breath for more than 20 seconds with coaching. In this study, 6 irradiation subfields were chosen, which allowed patients to take 5 breaks throughout the treatment. The beam-on time for each field was about 15 seconds. The beam was turned on 2-3 seconds after a breath was held, to further reduce the variation of tumor movements and relieve patient fatigue due to repetitive breath control (35) . Further clinical studies are warranted to validate the reproducibility and stability of ABC techniques in SBRT. Image-guided technology allows pretreatment imaging and could further increase the precision of target localization with 3D-CRT when combined with ABC in patients with early-stage NSCLC, and non-coplanar plans could also achieve better outcomes (5, 8, 36, 37) .
In conclusion, the results from this study suggest that highdose-rate 3D-CRT combined with ABC could be a superior radiation delivery method for SBRT of early NSCLC patients with normal cardiopulmonary function.
